Virax Biolabs Group Limited (VRAX) Ownership

$3.11

north_east
$0.68 (27.98%)
Day's range
$2.33
Day's range
$3.2

Virax Biolabs Group Limited Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
UBS GROUP AG 02/14/2025 37,915 $85,309   84.68% 1.89%
XTX TOPCO LTD 02/13/2025 11,863 $26,692   100.00% 0.59%
ROYAL BANK OF CANADA 02/14/2025 10,400 $23,000   100.00% 0.52%
01/23/2025 2,700 $6,075   100.00% 0.13%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 02/11/2025 20 $45   100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 9 $20   100.00% 0.00%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 0 $0   -100.00% 0.00%
HEADLANDS TECHNOLOGIES LLC 02/12/2025 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 02/14/2025 0 $0   -100.00% 0.00%
SQUAREPOINT OPS LLC 02/14/2025 0 $0   -100.00% 0.00%

Virax Biolabs Group Limited institutional Ownership - FAQ's

During the previous two years, 9 institutional investors and hedge funds held shares of Virax Biolabs Group Limited. The most heavily invested institutionals were:

UBS Group AG: 37,915

XTX Topco Ltd: 11,863

ROYAL BANK OF CANADA: 10,400

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 20

Tower Research Capital LLC (TRC): 9

RENAISSANCE TECHNOLOGIES LLC: 0

3.14% of Virax Biolabs Group Limited stock is owned by institutional investors.

Institutional investors have bought a total of 60,207 shares in the last 24 months. This purchase volume represents approximately $187,244 in transactions.